Philosophy of Care
Dr. Alnimri is interested in desensitization protocols and new trials in immunosuppression.
Cypress Building, Transplant Surgery
2221 Stockton Blvd., Suite B
Sacramento, CA 95817
King Hussein Medical Center, 1988-1993
Unity Health System, Rochester NY 2006-2008
Royal Medical Services, 1988-1993
University of California, San Francisco CA 2008-2009
American Board of Nephrology, 2009
American Society of Nephrology
American Society of Transplantation
International Society of Nephrology
Royal College of Physicians (UK)
Select Honors and Awards:
Fellow of the Royal College of Physicians UK, 2005
Honorary Registrar University College, London, 2001
Select Recent Publications:
Alnimri M, Laftavi MR, Kohli R, Said M, Feng L, Patel S, Pankewycz O. African-American women and older patients are at risk for a greater decline in renal function following living kidney donation. Transplant Proc. 2011 Mar;43(2):512-5.
Laftavi MR, Alnimri M, Weber-Shrikant E, Kohli R, Said M, Patel S, Pankewycz O. Low-dose rabbit antithymocyte globulin versus basiliximab induction therapy in low-risk renal transplant recipients: 8-year follow-up. Transplant Proc. 2011 Mar;43(2):458-61.
Laftavi MR, Hai F, Laftavi H, Feng L, Said M, Patel S, Kohli R, Alnimri M, Dayton M, Pankewycz O. Mycophenolic acid dose reductions result in poor long-term renal allograft survival: comparison between mycophenolate sodium and mycophenolate mofetil. Transplant Proc. 2011 Mar;43(2):478-81.
Laftavi MR, Patel S, Soliman MR, Alnimri M, Kohli R, Said M, Pankewycz O. Low-dose thymoglobulin use in elderly renal transplant recipients is safe and effective induction therapy. Transplant Proc. 2011 Mar;43(2):466-8.
Pankewycz O, Leca N, Kohli R, Wallace PK, Said M, Feng L, Alnimri M, Patel S, Laftavi MR. Low-dose rabbit antithymocyte globulin induction therapy results in prolonged selective lymphocyte depletion irrespective of maintenance immunosuppression. Transplant Proc. 2011 Mar;43(2):462-5.
Pankewycz O, Leca N, Kohli R, Weber-Shrikant E, Said M, Alnimri M, Feng L, Patel S, Laftavi MR. Conversion to low-dose tacrolimus or rapamycin 3 months after kidney transplantation: a prospective, protocol biopsy-guided study. Transplant Proc. 2011 Mar;43(2):519-23.
Patel S, Pankewycz O, Kohli R, Said M, Alnimri M, Feng L, Laftavi MR. Obesity in renal transplantation: the role of induction therapy on long-term outcomes. Transplant Proc. 2011 Mar;43(2):469-71.
Muna A. Al- Nimri, Radko Komers, Terry T. Oyama, Arohan R. Subramanya, Jessie N. Lindsley, and Sharon Anderson. Endothelial derived vasoactive mediators in polycystic kidney disease. Kidney International 2003 63(5): 1776-1784
Muna Al Nimri, Maan Hadidi. Acute renal failure after cardiac catheterization and coronary artery bypass graft in an elderly patient. Saudi Journal of Kidney Diseases and Transplantation 2002 13(1): 55-59
Thomas M. Kennefick, Muna A. Al-Nimri, Terry T. Oyama, Michelle M. Thompson, Francis J. Kelly, Justin G. Chapman, and Sharon Anderson. Hypertension and renal injury in experimental polycystic kidney disease. Kidney International 1999 56(6): 2181-2190